Active Ingredient(s): Nebivolol + Valsartan
FDA Approved: * June 3, 2016
Pharm Company: * FOREST LABS LLC
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Byvalson Overview

Nebivolol is a β1 receptor blocker with nitric oxide-potentiating vasodilatory effect used in treatment of hypertension and, in Europe, also for left ventricular failure.[1] It is highly cardioselective under certain circumstances.[1] Nebivolol has also been paired with another blood pressure lowering medication, the angiotensin receptor blocker valsartan. Contents 1 Pharmacology and biochemistry 1.1 β1-selectivity 1.2 Vasodilator action 1.3 Ant...

Read more Byvalson Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Byvalson Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Nebivolol + Valsartan
  • Tablet: 5mg + 80mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Byvalson: (1 result)

Sorted by National Drug Code
  • 0023-5874 Byvalson Oral Tablet, Film Coated by Allergan, Inc

Drugs with one or more similar ingredients: (16 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA